News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Longcor Jarrod
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/18/2023 |
4
| Longcor Jarrod (COO) has filed a Form 4 on Cellectar Biosciences, Inc.
Txns:
| Granted 144,000 options to buy
@ $1.68, valued at
$241.9k
|
|
01/27/2022 |
4
| Longcor Jarrod (Chief Business Officer) has filed a Form 4 on Cellectar Biosciences, Inc.
Txns:
| Granted 475,000 options to buy
@ $0.55, valued at
$261.3k
|
|
03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/28/2020 |
4
| Longcor Jarrod (Chief Business Officer) has filed a Form 4 on Cellectar Biosciences, Inc.
Txns:
| Bought 29,630 shares
@ $1.35, valued at
$40k
|
|
06/08/2020 |
4
| Longcor Jarrod (Chief Business Officer) has filed a Form 4 on Cellectar Biosciences, Inc.
Txns:
| Bought 65,218 shares
@ $1.145, valued at
$74.7k
Bought 32,609 options to buy
@ $1.2075, valued at
$39.4k
|
|
03/05/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
02/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/18/2019 |
4
| Longcor Jarrod (Chief Business Officer) has filed a Form 4 on Cellectar Biosciences, Inc.
Txns:
| Granted 30,000 options to buy
@ $1.99, valued at
$59.7k
|
|
10/15/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/17/2018 |
4
| Longcor Jarrod (Chief Business Officer) has filed a Form 4 on Cellectar Biosciences, Inc.
Txns:
| Bought 500 shares
@ $2.71, valued at
$1.4k
|
|
03/14/2018 |
4
| Longcor Jarrod (Chief Business Officer) has filed a Form 4 on Cellectar Biosciences, Inc.
Txns:
| Sold 13,000 shares
@ $1.1844, valued at
$15.4k
|
|
09/25/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
08/12/2016 |
4
| Longcor Jarrod (Sr. VP of Corp Dev & Ops) has filed a Form 4 on Cellectar Biosciences, Inc.
Txns:
| Granted 75,000 options to buy
@ $2.93, valued at
$219.8k
|
|
08/12/2016 |
3
| Longcor Jarrod (Sr. VP of Corp Dev & Ops) has filed a Form 3 on Cellectar Biosciences, Inc. |
|
|